CA3, carbonic anhydrase 3, 761

N. diseases: 37; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0013264
Disease: Muscular Dystrophy, Duchenne
Muscular Dystrophy, Duchenne 		0.020 AlteredExpression disease BEFREE The difference between the CK and CAIII results could indicate biochemical heterogeneity in the expression of Duchenne muscular dystrophy. 3925781 1985
CUI: C0013264
Disease: Muscular Dystrophy, Duchenne
Muscular Dystrophy, Duchenne 		0.020 Biomarker disease BEFREE Fetal plasma carbonic anhydrase III in prenatal diagnosis of Duchenne muscular dystrophy. 3918446 1985
CUI: C0019207
Disease: Hepatoma, Morris
Hepatoma, Morris 		0.200 Biomarker disease CTD_mouse Expression profiling and identification of novel genes in hepatocellular carcinomas. 11420682 2001
CUI: C0019208
Disease: Hepatoma, Novikoff
Hepatoma, Novikoff 		0.200 Biomarker disease CTD_mouse Expression profiling and identification of novel genes in hepatocellular carcinomas. 11420682 2001
CUI: C0023904
Disease: Liver Neoplasms, Experimental
Liver Neoplasms, Experimental 		0.200 Biomarker phenotype CTD_mouse Expression profiling and identification of novel genes in hepatocellular carcinomas. 11420682 2001
CUI: C0086404
Disease: Experimental Hepatoma
Experimental Hepatoma 		0.200 Biomarker disease CTD_mouse Expression profiling and identification of novel genes in hepatocellular carcinomas. 11420682 2001
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.030 Biomarker group BEFREE Furthermore, the reduction of CAI, CAII and CAIII in HCC tumor areas was also revealed in this study and this reduction might promote tumor cell motility and contribute to tumor growth and metastasis. 12927591 2003
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction 		0.010 Biomarker disease LHGDN Serum myoglobin/carbonic anhydrase III ratio in the diagnosis of perioperative myocardial infarction during coronary bypass surgery. 12745799 2003
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.010 Biomarker phenotype BEFREE Furthermore, the reduction of CAI, CAII and CAIII in HCC tumor areas was also revealed in this study and this reduction might promote tumor cell motility and contribute to tumor growth and metastasis. 12927591 2003
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma 		0.010 Biomarker disease BEFREE Furthermore, the reduction of CAI, CAII and CAIII in HCC tumor areas was also revealed in this study and this reduction might promote tumor cell motility and contribute to tumor growth and metastasis. 12927591 2003
CUI: C0023893
Disease: Liver Cirrhosis, Experimental
Liver Cirrhosis, Experimental 		0.500 Biomarker disease CTD_human Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. 17072980 2006
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion 		0.010 AlteredExpression phenotype BEFREE Silencing of FAK expression in CAIII transfectants led to suppression of HCC cell invasion. 18444244 2008
CUI: C0028754
Disease: Obesity
Obesity 		0.310 Biomarker disease CTD_human Orchestrated downregulation of genes involved in oxidative metabolic pathways in obese vs. lean high-fat young male consumers. 20882379 2011
CUI: C0023051
Disease: Laryngeal Diseases
Laryngeal Diseases 		0.010 AlteredExpression group BEFREE Carbonic anhydrase III levels vary in the larynx in response to laryngopharyngeal reflux, depending on location. 21914248 2011
CUI: C1168250
Disease: Laryngopharyngeal Reflux
Laryngopharyngeal Reflux 		0.010 AlteredExpression disease BEFREE Carbonic anhydrase III levels vary in the larynx in response to laryngopharyngeal reflux, depending on location. 21914248 2011
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.030 AlteredExpression group BEFREE S100A10 (p11), major vault protein, guanylate-binding protein 1(GBP1), and carbonic anhydrase III (CAIII) were identified to have significantly increased expression in EGFRvIII expressing xenograft tumors relative to wtEGFR xenograft tumors. 22964225 2012
CUI: C0019193
Disease: Hepatitis, Toxic
Hepatitis, Toxic 		0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C0023893
Disease: Liver Cirrhosis, Experimental
Liver Cirrhosis, Experimental 		0.500 Biomarker disease CTD_mouse Systems level analysis and identification of pathways and networks associated with liver fibrosis. 25380136 2014
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease 		0.500 Biomarker phenotype CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C1262760
Disease: Hepatitis, Drug-Induced
Hepatitis, Drug-Induced 		0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C3658290
Disease: Drug-Induced Acute Liver Injury
Drug-Induced Acute Liver Injury 		0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C4277682
Disease: Chemical and Drug Induced Liver Injury
Chemical and Drug Induced Liver Injury 		0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C4279912
Disease: Chemically-Induced Liver Toxicity
Chemically-Induced Liver Toxicity 		0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C0015695
Disease: Fatty Liver
Fatty Liver 		0.210 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis 		0.210 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014